Literature DB >> 9203726

The effect of diarrhea on oral poliovirus vaccine failure in Brazil.

D L Posey1, R W Linkins, M J Oliveria, D Monteiro, P A Patriarca.   

Abstract

The effect of diarrhea on oral poliovirus vaccine (OPV) failure was evaluated using data from Brazil, where 728 infants were immunized at birth (OPV1) and approximately 6 (OPV2), 10 (OPV3), and 14 (OPV4) weeks. Recent diarrhea history was significantly associated with increased vaccine failure only after OPV2 for poliovirus types 2 and 3. In multivariate models, controlling for breast feeding, season of vaccine administration (type 3 only), maternal antibody (type 3 only), and immunization campaign exposure (type 3 only) strengthened this effect. Diarrhea at OPV receipt was associated with vaccine failure to poliovirus types 1 and 3 only after OPV2. These data support the current recommendation that children with diarrhea receive OPV and be reimmunized once their illness resolves. Expanding this recommendation to include children with a recent diarrhea history should be considered. While the effect of diarrhea on vaccine failure may be limited to OPV2, programmatic realities may preclude dose-specific recommendations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203726     DOI: 10.1093/infdis/175.supplement_1.s258

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Oral and inactivated poliovirus vaccines in the newborn: a review.

Authors:  Farrah J Mateen; Russell T Shinohara; Roland W Sutter
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

2.  Controversies in polio immunization.

Authors:  Naveen Thacker; Niranjan Shendurnikar
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

Review 3.  Oral rotavirus vaccines: how well will they work where they are needed most?

Authors:  Manish Patel; Andi L Shane; Umesh D Parashar; Baoming Jiang; Jon R Gentsch; Roger I Glass
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

Review 4.  Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Authors:  Steven G F Wassilak; M Steven Oberste; Rudolph H Tangermann; Ousmane M Diop; Hamid S Jafari; Gregory L Armstrong
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

5.  The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.

Authors:  Kathleen M O'Reilly; Elias Durry; Obaid ul Islam; Arshad Quddus; Ni'ma Abid; Tahir P Mir; Rudi H Tangermann; R Bruce Aylward; Nicholas C Grassly
Journal:  Lancet       Date:  2012-07-04       Impact factor: 79.321

6.  Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study.

Authors:  Philip J Cooper; Martha E Chico; Irene Guadalupe; Carlos A Sandoval; Edward Mitre; Thomas A E Platts-Mills; Mauricio L Barreto; Laura C Rodrigues; David P Strachan; George E Griffin
Journal:  BMC Infect Dis       Date:  2011-06-29       Impact factor: 3.090

Review 7.  Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.

Authors:  Edward P K Parker; Beate Kampmann; Gagandeep Kang; Nicholas C Grassly
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

8.  Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.

Authors:  Mami Taniuchi; James A Platts-Mills; Sharmin Begum; Md Jashim Uddin; Shihab U Sobuz; Jie Liu; Beth D Kirkpatrick; E Ross Colgate; Marya P Carmolli; Dorothy M Dickson; Uma Nayak; Rashidul Haque; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2016-05-03       Impact factor: 3.641

9.  Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.

Authors:  Fatima Mir; Farheen Quadri; Ondrej Mach; Imran Ahmed; Zaid Bhatti; Asia Khan; Najeeb Ur Rehman; Elias Durry; Maha Salama; Steven M Oberste; William C Weldon; Roland W Sutter; Anita K M Zaidi
Journal:  Lancet Infect Dis       Date:  2015-06-17       Impact factor: 25.071

10.  Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.

Authors:  James A Church; Sandra Rukobo; Margaret Govha; Marya P Carmolli; Sean A Diehl; Bernard Chasekwa; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Beth D Kirkpatrick; Andrew J Prendergast
Journal:  Hum Vaccin Immunother       Date:  2017-08-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.